Zelnorm For Chronic Constipation Should Exclude Males And Seniors – Cmte.
Executive Summary
Novartis' Zelnorm should be approved for treatment of patients with chronic constipation who are under 65 years of age and female, FDA's Gastrointestinal Drugs Advisory Committee recommended July 14